It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 02352cam 2200553Ia 4500
001 ocm27709064
003 OCoLC
005 20160201024420.0
008 930311t19931992nyu b 001 0 eng d
010 $a 90055947
040 $aTMS$beng$cTMS$dBAKER$dOCLCG$dYDXCP$dOCLCQ$dOCLCO$dOCLCF$dOCLCQ$dOCLCO$dOCLCQ
020 $a0060183098$q(cloth)
020 $a9780060183097$q(cloth)
020 $a0060923598$q(pbk.)
020 $a9780060923594$q(pbk.)
035 $a(OCoLC)27709064
043 $an-us---
050 4 $aRA644.A25$bA76 1993
060 4 $aWD 308 A751a 1993
082 00 $a362.1/969792$220
100 1 $aArno, Peter S.,$d1954-
245 10 $aAgainst the odds :$bthe story of AIDS drug development, politics, and profits /$cPeter S. Arno and Karyn L. Feiden.
250 $a1st HarperPerennial ed.
260 $aNew York :$bHarperCollins,$c1993, ℗♭1992.
300 $axviii, 314 pages ;$c21 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $a"HarperPerennial."
504 $aIncludes bibliographical references (pages 273-302) and index.
650 0 $aAIDS (Disease)$xGovernment policy$zUnited States.
650 0 $aAIDS (Disease)$xChemotherapy.
650 0 $aDrugs$xTesting$xGovernment policy$zUnited States.
650 2 $aAcquired Immunodeficiency Syndrome$zUnited States$xHistory.
650 2 $aClinical Trials.
650 2 $aDrugs, Investigational$xHistory.
650 2 $aHealth Policy$zUnited States$xHistory.
650 7 $aAIDS (Disease)$xChemotherapy.$2fast$0(OCoLC)fst00793814
650 7 $aAIDS (Disease)$xGovernment policy.$2fast$0(OCoLC)fst00793839
650 7 $aDrugs$xTesting$xGovernment policy.$2fast$0(OCoLC)fst00898943
651 7 $aUnited States.$2fast$0(OCoLC)fst01204155
700 1 $aFeiden, Karyn.
776 08 $iOnline version:$aArno, Peter S., 1954-$tAgainst the odds.$b1st HarperPerennial ed.$dNew York : HarperCollins, 1993, ℗♭1992$w(OCoLC)752602175
938 $aBaker & Taylor$bBKTY$c12.00$d9.00$i0060923598$n0002258042$sactive
938 $aYBP Library Services$bYANK$n29096
952 $a27709064$zTMS$hFull OCLC member$iLCC$jNLM$kDDC$u20150605
952 $a125925072$zCWCLL$bWHITTIER COL SCH OF LAW$hFull$iLCC$kDDC$u20100714
994 $aZ0$bPMR
948 $hNO HOLDINGS IN PMR - 68 OTHER HOLDINGS